ReviewInternational journal of transgender health2026
A systematic review of functional neurological disorder in transgender people.
Review in International journal of transgender health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Trans and gender diverse people may be more likely to have a functional neurological disorder (FND), although the reasons for this are unclear. This systematic review examines the relationship between trans people and FND, to determine if one population is overrepresented in the other, and if gender affirming-care affects symptoms of FND. Methods: A systematic review was conducted as per PRISMA guidelines. Searches were performed on OVID (MEDLINE), PsycINFO, and Web of Science. Studies included focused on both FND and trans people, had subjects of any age, and were original research articles. When the study referred to somatic symptom and related disorders it was included. Study quality was assessed using JBI's critical appraisal tools. Results: Fourteen studies were included. Seven examined the prevalence of FND (or likely FND) in trans people, or of trans people in people in FND or (likely FND patient populations), and seven were case studies or series of trans people with probable FND (total cases = 20). Trans people made up 3-45% of people with FND; somatic symptom and related disorders were present in 6-9.7% of trans people (compared to 5-7% in the general population). Fifteen of the 20 cases were trans people assigned female at birth. Ten of the 20 cases developed FND prior to their social gender affirmation, and seven of those ten's symptoms resolved with gender affirmation. Discussion: Trans people were more likely to develop FND, and somatic symptom and related disorders were slightly overrepresented in trans people. Gender affirmation can lead to resolution of FND symptoms. Trans people appear to make up a considerable proportion of people with FND. FND treatment services need to consider how they provide trans affirming services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.